Concepedia

Author

Jane Armitage

University of OxfordORCID

Also Known As

Armitage, Jane, Collins, Rory, J Armitage, J M Armitage, J. ARMITAGE, J. Armitage, J. M. ARMITAGE, J. M. Armitage, J.M. Armitage, JANE ARMITAGE

157

Publications

14.5K

Citations

42

H-Index

69

Concepts

All Affiliations

University of OxfordMedical Research CouncilJohn Radcliffe HospitalUniversity College LondonUniversity of Cambridge
JA

About

Jane Armitage is an author at University of Oxford specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

16

3.7K

2

Public Health

6

6

648

3

Arts

1

1

11

4

Health Sciences

1

1

19

5

Law

1

1

19

Jane Armitage

×

55

Publications

6.1K

Citations

29

H-Index

YearCitations

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent, Martin Landray, Christina Reith,

The Lancet

2011

2.4K

Heart Protection Study

Rory Collins, Jane Armitage, Sarah Parish,

The Lancet

2003

490

Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors

Emanuele Di Angelantonio, Simon G. Thompson, Stephen Kaptoge,

The Lancet

2017

291

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

Lara M. Mangravite, Barbara E. Engelhardt, Marisa W. Medina,

Nature

2013

230

Phenotype Standardization for Statin-Induced Myotoxicity

Ana Alfirevic, D. Neely, Jane Armitage,

Clinical Pharmacology & Therapeutics

2014

217

Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

Sarah Parish, Alison Offer, Robert Clarke,

Circulation

2012

212

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

Colin Baigent, Martin Landray, Craig Leaper,

American Journal of Kidney Diseases

2005

202

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials

Emily Herrett, Elizabeth Williamson, Kieran E. Brack,

BMJ

2021

175

The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD

Martin Landray, Colin Baigent, Craig Leaper,

American Journal of Kidney Diseases

2006

108

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study

Jemma C. Hopewell, Sarah Parish, Alison Offer,

European Heart Journal

2012

106

Page 1